{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:24:36Z","timestamp":1787304276036,"version":"build-2736575974"},"reference-count":52,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background:\u00a0Streptococcus agalactiae (group B Streptococcus, GBS) remains a leading cause of invasive infections in pregnant women, fetuses, and neonates. Universal screening at 36\u201337 weeks of gestation and intrapartum antimicrobial prophylaxis are essential to prevent adverse outcomes. This study aimed to determine the prevalence, serotype distribution, and antimicrobial susceptibility of GBS isolates among pregnant women in Greece. Methods: Vaginal and rectal swabs were collected from pregnant women undergoing GBS screening between January 2021 and December 2025. Samples were processed using Todd-Hewitt broth with colistin and nalidixic acid, and cultured on blood agar and chromogenic media. The VITEK2 system was used for GBS identification and antimicrobial susceptibility testing against penicillin, erythromycin, clindamycin, tetracycline, levofloxacin, and vancomycin, according to EUCAST guidelines. The double-disk diffusion test was used for macrolide-lincosamide-streptogramin B (MLSB) phenotyping. Serotyping for all ten serotypes was conducted using a commercial latex agglutination assay. Results: Among 941 women screened, 118 (12.5%) were colonized with GBS. The most prevalent serotypes were III (29.7%), V (18.6%), Ib (14.4%), IX (10.2%), Ia (9.3%), and II (9.3%). All isolates were susceptible to penicillin. Resistance to erythromycin and\/or clindamycin was detected in 37 isolates. In these isolates, the predominant MLSB phenotype was constitutive (cMLSB, 78.4%), followed by inducible (iMLSB, 13.5%), L (5.4%), and M (2.7%) phenotypes. Conclusions: GBS colonization was detected in 12.5% of pregnant women, with serotype III predominating, underscoring its clinical relevance due to its association with invasive neonatal disease. Although penicillin remains fully effective, the observed resistance to macrolides and lincosamides, primarily mediated by the cMLSB phenotype, raises concerns regarding alternative therapies.<\/jats:p>","DOI":"10.3390\/jcm15166458","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:19Z","timestamp":1787241919000},"page":"6458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, Serotype Distribution, and Antimicrobial Resistance of Streptococcus agalactiae Among Pregnant Women in Greece: A Retrospective Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Anthia","family":"Chasiakou","sequence":"first","affiliation":[{"name":"Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kaparos","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia","family":"Chasiakou","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stiliani","family":"Demeridou","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Aretaieion University Hospital, National and Kapodistrian University of Athens, 76 Vassilisis Sofias Avenue, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Koumaki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-4715","authenticated-orcid":false,"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/cix653","article-title":"Group B streptococcal disease worldwide for pregnant women, stillbirths, and children: Why, what, and how to undertake estimates?","volume":"65","author":"Lawn","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.jmb.2019.01.035","article-title":"The double life of group B streptococcus: Asymptomatic colonizer and potent pathogen","volume":"431","author":"Armistead","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: Estimates of regional and global burden","volume":"10","author":"Procter","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"The American College of Obstetricians and Gynecologists (2020). Prevention of group B streptococcal Early-Onset disease in newborns: ACOG committee opinion, number 797. Obstet. Gynecol., 135, e51\u2013e72.","DOI":"10.1097\/AOG.0000000000003668"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B streptococcus and serotype distribution worldwide: Systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41390-022-02375-3","article-title":"Evolving antibiotic resistance in group B streptococci causing invasive infant disease: 1970\u20132021","volume":"93","author":"Sabroske","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/1040841X.2020.1758626","article-title":"A review of antibiotic resistance in Group B Streptococcus: The story so far","volume":"46","author":"Hayes","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Berbel, D., Gonzalez-Diaz, A., de Egea, G.L., C\u00e0mara, J., and Ardanuy, C. (2022). An overview of macrolide resistance in Streptococci: Prevalence, mobile elements and dynamics. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122316"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gergova, R., Boyanov, V., Muhtarova, A., and Alexandrova, A. (2024). A review of the impact of streptococcal infections and antimicrobial resistance on human health. Antibiotics, 13.","DOI":"10.3390\/antibiotics13040360"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","article-title":"Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: A phase \u00bd, randomised, placebo-controlled, observer-blinded, dose-escalation trial","volume":"21","author":"Absalon","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.00117-07","article-title":"Serotype IX, a proposed new Streptococcus agalactiae serotype","volume":"45","author":"Slotved","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: Systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3201\/eid2210.151436","article-title":"Hypervirulent clone of group B Streptococcus serotype III sequence type 283, Hong Kong, 1993\u20132012","volume":"22","author":"Ip","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Campisi, E., Rosini, R., Ji, W., Guidotti, S., Rojas-Lopez, M., Geng, G., Deng, Q., Zhong, H., Wang, W., and Liu, H. (2016). Genomic analysis reveals multi-drug resistance clusters in group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in southern mainland China. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01265"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"107083","DOI":"10.1016\/j.mimet.2024.107083","article-title":"I-dOne: A diagnostic tool in the field of identification of clinically relevant microbial strains","volume":"228","author":"Camarlinghi","year":"2025","journal-title":"J. Microbiol. Methods"},{"key":"ref_16","unstructured":"EUCAST, and The European Committee on Antimicrobial Susceptibility Testing (2026, June 26). Clinical Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 15.0 Basel (Switzerland). Available online: https:\/\/www.eucast.org\/bacteria\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-tables\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1469-0691.2003.00662.x","article-title":"Group B streptococcus colonization of Greek pregnant women and neonates: Prevalence, risk factors and serotypes","volume":"9","author":"Tsolia","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000089298","article-title":"Bacterial vaginosis and group B streptococcal colonization and preterm delivery in a low-risk population","volume":"21","author":"Daskalakis","year":"2006","journal-title":"Fetal Diagn. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3855\/jidc.10367","article-title":"Antenatal group B streptococcus detection in pregnant women: Culture or PCR?","volume":"12","author":"Gerolymatos","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"114913","DOI":"10.1016\/j.ejogrb.2025.114913","article-title":"Group B Streptococcus colonization in pregnant women and vertical transmission to neonates in Crete Greece: Incidence and risk factors","volume":"318","author":"Vardaki","year":"2026","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5603\/gpl.102721","article-title":"The prevalence of group B Streptococcus rectovaginal colonization and antimicrobial susceptibility pattern in Turkish and Syrian pregnant women","volume":"96","author":"Kirtis","year":"2025","journal-title":"Ginekol. Pol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41598-020-79354-3","article-title":"Trends in molecular characteristics and antimicrobial resistance of group B streptococci: A multicenter study in Serbia, 2015\u20132020","volume":"11","author":"Kekic","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bogn\u00e1r, Z., Leroy, C., Van Leeuw, V., Goemaes, R., Melin, P., Meex, C., Sacheli, R., Camfferman, F., Litzroth, A., and De Keersmaeker, F. (2025). Group B Streptococcus maternal colonization and neonatal sepsis in Belgium between 2012 and 2021: A description of the epidemiological situation and identification of risk factors. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07695-w"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jclinpath-2017-204646","article-title":"Incidence and serotype characterization of Streptococcus agalactiae in a Portuguese hospital","volume":"71","author":"Pinto","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Slotved, H.C., M\u00f8ller, J.K., Khalil, M.R., and Nielsen, S.Y. (2021). The serotype distribution of Streptococcus agalactiae (GBS) carriage isolates among pregnant women having risk factors for early-onset GBS disease: A comparative study with GBS causing invasive infections during the same period in Denmark. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06820-2"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shabayek, S., and Spellerberg, B. (2018). Group B streptococcal colonization, molecular characteristics, and epidemiology. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00437"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00049-18","DOI":"10.1128\/CMR.00049-18","article-title":"Perinatal Streptococcus agalactiae epidemiology and surveillance targets","volume":"31","author":"Furfaro","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.diagmicrobio.2013.12.017","article-title":"Molecular characterization of Streptococcus agalactiae from vaginal colonization and neonatal infections: A 4-year multicenter study in Greece","volume":"78","author":"Liakopoulos","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"w13935","DOI":"10.4414\/smw.2014.13935","article-title":"Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: Results from a Swiss tertiary centre","volume":"144","author":"Surbek","year":"2014","journal-title":"Swiss Med. Wkly."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Jamrozy, D., Gopal Rao, G., Feltwell, T., Lamagni, T., Khanna, P., Efstratiou, A., Parkhill, J., and Bentley, S.D. (2023). Population genetics of group B Streptococcus from maternal carriage in an ethnically diverse community in London. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1185753"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10096-020-03992-8","article-title":"Streptococcus agalactiae in pregnant women: Serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy)","volume":"39","author":"Genovese","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.33073\/pjm-2024-042","article-title":"Antibiotic resistance and serotypes distribution in Streptococcus agalactiae Bulgarian clinical isolates during the years of 2021\u20132024","volume":"73","author":"Boyanov","year":"2024","journal-title":"Pol. J. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41598-024-54521-y","article-title":"Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland","volume":"14","author":"Kaminska","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/cix896","article-title":"Clinical and laboratory features of group B Streptococcus meningitis in infants and newborns: Study of 848 cases in France from 2001\u20132014","volume":"66","author":"Romain","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gudjonsdottir, M.J., Hentz, E., Berg, S., Backhaus, E., Elfvin, A., Kawash, S., and Trollfors, B. (2015). Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1266-4"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/INF.0000000000000732","article-title":"Ultra-late-onset meningitis caused by serotype IX group B Streptococcus","volume":"34","author":"Takahara","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12941-019-0313-1","article-title":"Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: A meta-analysis","volume":"18","author":"Gizachew","year":"2019","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shabayek, S., Ferrieri, P., and Spellerberg, B. (2021). Group B streptococcal colonization in African countries: Prevalence, capsular serotypes, and molecular sequence types. Pathogens, 10.","DOI":"10.3390\/pathogens10121606"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Systematic review of group B streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates","volume":"38","author":"Paul","year":"2020","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hsu, C.Y., Moradkasani, S., Suliman, M., Uthirapathy, S., Zwamel, A.H., Hjazi, A., Vashishth, R., and Beig, M. (2025). Global patterns of antibiotic resistance in group B Streptococcus: A systemic review and meta-analysis. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1541524"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/31.1.177","article-title":"Inducible type of erythromycin resistance among groups B streptococci isolated in Greece","volume":"31","author":"Tsakris","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12941-023-00553-7","article-title":"Maternal colonization with group B Streptococcus and antibiotic resistance in China: Systematic review and meta-analyses","volume":"22","author":"Wang","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1128\/AAC.01374-16","article-title":"Changing epidemiology of group B Streptococcus susceptibility to fluoroquinolones and aminoglycosides in France","volume":"60","author":"Hays","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129.e1","DOI":"10.1016\/j.cmi.2020.09.037","article-title":"Invasive group B Streptococcus infections in non-pregnant adults: A retrospective study, France, 2007\u20132019","volume":"27","author":"Vuillemin","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/mdr.2017.0139","article-title":"Molecular characterization of Italian isolates of fluoroquinolone-resistant Streptococcus agalactiae and relationships with chloramphenicol resistance","volume":"24","author":"Simoni","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5152\/balkanmedj.2021.20152","article-title":"Emergence of multidrug-resistant and hypervirulent Streptococcus agalactiae in Bulgarian patients","volume":"38","author":"Gergova","year":"2021","journal-title":"Balk. Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"106261","DOI":"10.1016\/j.isci.2023.106261","article-title":"Safety and immunogenicity of the group B Streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial","volume":"26","author":"Pawlowski","year":"2023","journal-title":"iScience"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"127575","DOI":"10.1016\/j.vaccine.2025.127575","article-title":"Progress towards a group B streptococcal vaccine-where are we now?","volume":"62","author":"Thorn","year":"2025","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B Streptococcus","volume":"389","author":"Mahdi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e0015422","DOI":"10.1128\/cmr.00154-22","article-title":"Group B streptococcal infections in pregnancy and early life","volume":"38","author":"Manuel","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"128706","DOI":"10.1016\/j.vaccine.2026.128706","article-title":"Pregnant women\u2019s knowledge, perceptions, and intention to receive a future group B Streptococcus (GBS) vaccine: A cross-sectional study","volume":"85","author":"Ladomenou","year":"2026","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6458\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:34:26Z","timestamp":1787301266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":52,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166458"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166458","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}